Patents by Inventor Jianxin Zhao

Jianxin Zhao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11446342
    Abstract: The present disclosure relates to the field of microbial technology, and discloses a composite probiotics and the use thereof. The composite probiotics in the present disclosure is consisted of Bifidobacterium adolescentis CCFM8630, Lactobacillus reuteri CCFM8631, Lactobacillus rhamnosus CCFM1044 and Lactobacillus casei CCFM711, whose effect of alleviating metabolic syndrome is significantly better than that of CCFM8630 or CCFM8631 alone or combination of the two, especially in aspects of lowering contents of serum low density lipoprotein, total cholesterol, and liver triglyceride and contents of serum alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase and IFN-?, and increasing contents of liver glutathione and superoxide dismutase, etc. The extent of decrease or increase is increased by 7.91% to 837.31% compared with the formulations of CCFM8630 or CCFM8631 alone or combination of the two probiotics. The combination of the four probiotics can achieve a significant synergistic effect.
    Type: Grant
    Filed: July 24, 2019
    Date of Patent: September 20, 2022
    Assignee: INFINITUS (CHINA) COMPANY LTD.
    Inventors: Fangli Ma, Wei Chen, Gang Wang, Xiaofeng Zhu, Yuanyuan Wang, Junyong Xiao, Hao Zhang, Jianxin Zhao
  • Publication number: 20220290095
    Abstract: Bifidobacterium breve CCFM1025, foods fermented thereby and an application thereof in the preparation of an anti-depression drug, an anti-inflammatory bowel disease drug, an anti-obesity drug, health products and functional foods.
    Type: Application
    Filed: August 22, 2018
    Publication date: September 15, 2022
    Inventors: Wei CHEN, Gang WANG, Peijun TIAN, Jianxin ZHAO, Hao ZHANG
  • Publication number: 20220288137
    Abstract: Bifidobacterium longum subsp. infantis CCFM687, a fermented food thereof, and an application of the same in preparing a drug, health care product, or food against depression, autism, inflammatory bowel disease, obesity, or type 1 diabetes.
    Type: Application
    Filed: August 22, 2018
    Publication date: September 15, 2022
    Inventors: Wei CHEN, Gang WANG, Peijun TIAN, Jianxin ZHAO, Hao ZHANG
  • Patent number: 11419905
    Abstract: The disclosure discloses Bacteroides ovatus for relieving endotoxin infection and application thereof, and belongs to the technical field of microorganisms. The Bacteroides ovatus CCFM1021 of the disclosure has low immunogenicity, and can reduce the content of pro-inflammatory factors and increase the concentration of anti-inflammatory factors in the blood of mice infected with endotoxin, up-regulate the number of Foxp3+ regulatory T cells and stabilize the composition of the intestinal microbiota. A pharmaceutical composition of the Bacteroides ovatus CCFM1021 for relieving endotoxin infection has broad application prospects.
    Type: Grant
    Filed: October 28, 2020
    Date of Patent: August 23, 2022
    Assignee: Jiangnan University
    Inventors: Wei Chen, Qixiao Zhai, Huizi Tan, Wenwei Lu, Fengwei Tian, Jianxin Zhao, Hao Zhang
  • Patent number: 11416719
    Abstract: The present disclosure provides a localization method as well as a helmet and a computer readable storage medium using the same. The method includes: extracting first feature points from a target image; obtaining inertial information of the carrier, and screening the first feature points based on the inertial information to obtain second feature points; triangulating the second feature points of the target image to generate corresponding initial three-dimensional map points, if the target image is a key frame image; performing a localization error loopback calibration on the initial three-dimensional map points according to at least a predetermined constraint condition to obtain target three-dimensional map points; and determining a positional point of the specific carrier according to the target three-dimensional map points. In this manner, the accuracy of the localization of a dynamic object such as a person when moving can be improved.
    Type: Grant
    Filed: September 3, 2020
    Date of Patent: August 16, 2022
    Assignee: UBTECH ROBOTICS CORP LTD
    Inventors: Chenchen Jiang, Zhichao Liu, Yongsheng Zhao, Yu Tang, Jianxin Pang, Youjun Xiong
  • Patent number: 11410156
    Abstract: An NFC payment method includes: displaying, by a first terminal, a third-party payment application based on a preset trigger condition; and interacting with a second terminal by using the third-party payment application, to complete NFC payment.
    Type: Grant
    Filed: June 30, 2017
    Date of Patent: August 9, 2022
    Assignee: Huawei Technologies Co., Ltd.
    Inventors: Jianxin Ding, Xiaona Zhao, Xinmiao Chang, Jingqing Mei
  • Publication number: 20220228106
    Abstract: The disclosure discloses a strain of Lactobacillus rhamnosus and application thereof in inhibiting Helicobacter pylori, and belongs to the technical fields of microorganisms and medicine. The disclosure provides a strain of Lactobacillus rhamnosus CCFM1119. The Lactobacillus rhamnosus CCFM1119 can prevent and/or treat Helicobacter pylori infection, specifically embodied in that: (1) the Lactobacillus rhamnosus CCFM1119 can significantly relieve the gastrointestinal symptoms of patients with Helicobacter pylori infection; (2) the Lactobacillus rhamnosus CCFM1119 can significantly reduce the amount of colonization of Helicobacter pylori in patients with Helicobacter pylori infection; and (3) the Lactobacillus rhamnosus CCFM1119 can significantly increase the clearance rate of Helicobacter pylori in patients with Helicobacter pylori infection.
    Type: Application
    Filed: April 1, 2022
    Publication date: July 21, 2022
    Inventors: Qixiao ZHAI, Wei CHEN, Jianxin ZHAO, Meiyi ZHANG, Shumao CUI, Wenwei LU, Fengwei TIAN, Leilei YU, Gang WANG, Hao ZHANG
  • Patent number: 11391939
    Abstract: An optical system of a stereo-video endoscope with a sideways viewing direction, the optical system including: a sideways-viewing distal optical assembly; and a proximal optical assembly; wherein the distal optical assembly includes an inlet lens, a deflecting unit configured as a prism unit, and an outlet lens on a common optical axis one after the other in the direction of light incidence, the proximal optical assembly includes a left and a right lens system channel, the lens system channels being identically configured and arranged parallel to each other, each lens system channel having its own optical axis, and the outlet lens is formed with one or more of a light-impermeable coating on a light inlet side facing the deflecting unit and with a light-impermeable coating formed on a light outlet side facing away from the deflecting unit in a central region of the outlet lens.
    Type: Grant
    Filed: July 30, 2020
    Date of Patent: July 19, 2022
    Assignee: OLYMPUS WINTER & IBE GMBH
    Inventor: Jianxin Zhao
  • Publication number: 20220218769
    Abstract: The disclosure discloses a strain of Lactobacillus crispatus capable of preventing and/or treating Helicobacter pylori infection, and belongs to the technical fields of microorganisms and medicine. The disclosure provides a strain of Lactobacillus crispatus CCFM1118. The Lactobacillus crispatus CCFM1118 can inhibit Helicobacter pylori, specifically embodied in that: (1) the diameter of an inhibition zone of supernatant of the Lactobacillus crispatus CCFM1118 on Helicobacter pylori can reach 13.14 mm; and (2) the Lactobacillus crispatus CCFM1118 can significantly reduce the adhesion of Helicobacter pylori to AGS cells. Therefore, the Lactobacillus crispatus CCFM1118 has great application prospects in inhibiting Helicobacter pylori (not for the purposes of disease diagnosis and treatment) and preparing Helicobacter pylori inhibitors.
    Type: Application
    Filed: March 31, 2022
    Publication date: July 14, 2022
    Inventors: Qixiao ZHAI, Wei CHEN, Meiyi ZHANG, Leilei YU, Fengwei TIAN, Shunhe WANG, Jianxin ZHAO, Hao ZHANG
  • Publication number: 20220211776
    Abstract: The disclosure discloses a B. breve strain capable of relieving rheumatoid arthritis and application thereof, and belongs to the technical field of microorganisms. The disclosure screens out a B. breve strain CCFM1078, and the B. breve CCFM1078 has the effect of relieving rheumatoid arthritis, being specifically embodied in: significantly promoting secretion of anti-inflammatory factor IL-10 from RAW264.7 cells; significantly reducing the joint thickness, clinical score and incidence of rats with rheumatoid arthritis; significantly decreasing the levels of pro-inflammatory cytokines TNF? and IL-1? in the serum of rats with rheumatoid arthritis; significantly regulating the content of short-chain fatty acids in the feces of rats with rheumatoid arthritis; significantly decreasing the proportion of Th17 cells in the mesenteric lymph nodes of rats with rheumatoid arthritis; and significantly reducing secretion of pro-inflammatory factor IL-6 from synovial cells.
    Type: Application
    Filed: March 17, 2022
    Publication date: July 7, 2022
    Inventors: Bo YANG, Wei CHEN, Zhexin FAN, Qixiao ZHAI, Gang WANG, Wenwei LU, Shumao CUI, Jianxin ZHAO, Hao ZHANG
  • Patent number: 11369648
    Abstract: The disclosure discloses a probiotic mixed preparation with anti-influenza ability and application thereof, and belongs to the technical fields of microorganisms and medicines. The probiotic mixed preparation has anti-influenza effects, which are embodied in: (1) significantly reducing the degree of weight loss of influenza mice; (2) significantly improving the blood indexes of the influenza mice; (3) significantly improving the inflammation status of respiratory tract infections in the influenza mice; (4) significantly reducing the viral load in the lungs of the influenza mice (i.e., significantly inhibiting the replication and multiplication of influenza viruses in the influenza mice); and (5) significantly increasing the expression quantity of antiviral protein MxA in the lungs of the influenza mice. Therefore, the probiotic mixed preparation has great application prospects in preparation of a product for preventing and/or treating atopic dermatitis and even preventing and/or treating influenza.
    Type: Grant
    Filed: June 4, 2020
    Date of Patent: June 28, 2022
    Assignee: JIANGNAN UNIVERSITY
    Inventors: Wei Chen, Wenwei Lu, Qixiao Zhai, Xinyang Liu, Jianxin Zhao, Feng Hang, Hao Zhang
  • Patent number: 11363942
    Abstract: An optical system for use with a stereo video endoscope with a fixed lateral viewing direction. The optical system including: a laterally-viewing distal optical assembly; and a proximal optical assembly, the distal optical assembly and proximal optical assembly jointly establishing a beam path, the proximal optical assembly including: a left channel lens system; and a right channel lens system similarly configured to the left channel lens system; wherein the distal optical assembly establishes an optical axis and is configured to couple incident light along the beam path from an object space into the left channel lens system and into the right channel lens system of the proximal optical assembly; and the optical system comprises an angle-selective optical element with a surface oriented perpendicular to the optical axis of the distal optical assembly, the surface being located in the beam path and coated with an incidence-angle-selective dielectric coating.
    Type: Grant
    Filed: March 22, 2019
    Date of Patent: June 21, 2022
    Assignee: OLYMPUS WINTER & IBE GMBH
    Inventors: Peter Schouwink, Jianxin Zhao
  • Patent number: 11357390
    Abstract: An optical system for a stereo video endoscope including: first and second lens system channels each having optical elements in identical configurations, the optical elements being arranged in a same position along first and second optical axes, respectively, an optical axis of first and second optical elements coincide with the first and second optical axes, respectively, first and second cross-sectional areas of the first and second optical elements are inscribed in first and second circumferential circles, respectively, centers of first and second circumferential circles each coincide with the first and second optical axes, respectively, to define a maximum radius of the first optical element and the second optical element, the first and second circumferential circles overlap one another, and circumferential shapes of the first and second optical elements deviate from the first and second circumferential circles circumscribing them such that the first and second optical elements do not contact.
    Type: Grant
    Filed: April 9, 2020
    Date of Patent: June 14, 2022
    Assignee: OLYMPUS WINTER & IBE GMBH
    Inventors: Martin Wieters, Peter Schouwink, Jianxin Zhao, Alrun Thuemen
  • Publication number: 20220152130
    Abstract: The present disclosure discloses multifunctional lactobacilli capable of relieving a toxic effect of perfluorooctanoic acid (PFOA) and use thereof, and belongs to the technical field of microorganisms.
    Type: Application
    Filed: December 27, 2021
    Publication date: May 19, 2022
    Inventors: Gang WANG, Wei CHEN, Jianxin ZHAO, Hao ZHANG, Xi LIANG, Qingmin KONG, Qixiao ZHAI, Wenwei LU, Shumao CUI, Bo YANG, Bingyong MAO
  • Patent number: 11317788
    Abstract: An optical system for use with a stereo video endoscope with a fixed, lateral viewing direction, including: laterally-viewing distal and proximal optical assemblies, similarly configured left and right lens system channels; the distal optical assembly couples incident light from an object space into the left and right lens system channels; the distal optical assembly includes an entrance lens, a deflection prism group and an exit lens in a direction of incident light; the deflection prism group includes first and second prisms in the direction of incident light; the first prism includes first entrance and first exit sides at an angle relative thereto; the second prism includes a second entrance side, a reflection side and a second exit side; and the first entrance side of the first prism and the reflection side of the second prism enclose an angle that is greater than a total reflection angle of the second prism.
    Type: Grant
    Filed: January 29, 2019
    Date of Patent: May 3, 2022
    Assignee: OLYMPUS WINTER & IBE GMBH
    Inventors: Peter Schouwink, Jianxin Zhao
  • Patent number: 11291697
    Abstract: The present disclosure relates to the field of microbial technology, and discloses a probiotic composition and use thereof. The probiotic composition in the present disclosure is consisted of Bifidobacterium adolescentis CCFM8630, Lactobacillus reuteri CCFM8631 and Lactobacillus rhamnosus CCFM1044, whose effect of alleviating metabolic syndrome is significantly better than that of CCFM8630 or CCFM8631 alone or combination of the two, especially in aspects of lowering epididymal fat content, lowering fasting blood glucose level, lowering the area under sugar tolerance curve and lowering contents of serum low density lipoprotein and total cholesterol, improving liver antioxidant capacity and lowering serum IL-1? content, etc. The extent of decrease or increase is increased by 9.62% to 769.62% compared with formulations of a single probiotic or a combination of two probiotics. The combination of three probiotics achieves a significant synergistic effect.
    Type: Grant
    Filed: July 24, 2019
    Date of Patent: April 5, 2022
    Assignee: INFINITUS (CHINA) COMPANY LTD.
    Inventors: Yuanyuan Wang, Wei Chen, Gang Wang, Xiaofeng Zhu, Fangli Ma, Junyong Xiao, Hao Zhang, Jianxin Zhao
  • Publication number: 20220096570
    Abstract: The present invention relates to the technical field of microbes, in particular to a Lactobacillus plantarum which can significantly inhibit the occurrence of colorectal cancer, and its use thereof. The Lactobacillus plantarum strain CCFM164 has a deposit number CGMCC No. 14520, which has a good tolerance to gastric acid and bile salts, significantly alleviate the level of colorectal inflammation in colorectal cancer model mice, and can reduce the number of tumors in the colon and rectum of the model mice by regulating the Notch1, Notch2 signaling pathway and the expression of VEGFR2 molecule in colorectal tissue. In addition, the Lactobacillus plantarum CCFM164 can also improve the intestinal flora population and short-chain fatty acid levels in the intestine. The Lactobacillus plantarum CCFM164 is used to prepare a fermented food for the inhibition of the occurrence of colorectal cancer with wild applications.
    Type: Application
    Filed: July 19, 2018
    Publication date: March 31, 2022
    Inventors: Wei CHEN, Gang WANG, Eryin WANG, Jianxin ZHAO, Hao ZHANG
  • Publication number: 20220072067
    Abstract: The disclosure discloses P. acidilactici CCFM6432 for alleviating depression, food fermented thereby and application thereof. The P. acidilactici CCFM6432 of the disclosure can be used to prepare food, health-care products and drugs with the functions of resisting depression, resisting inflammation, resisting inflammatory bowel disease, resisting obesity and resisting type I diabetes. The disclosure further provides fermented food. The fermented food is produced by fermentation using the P. acidilactici CCFM6432, and the fermented food includes solid food, liquid food, and semi-solid food. The P. acidilactici CCFM6432 has very broad application prospects.
    Type: Application
    Filed: November 29, 2021
    Publication date: March 10, 2022
    Inventors: Gang WANG, Wei CHEN, Peijun TIAN, Jianxin ZHAO, Hao ZHANG
  • Publication number: 20220017886
    Abstract: Disclosed is linoleic acid isomerases and their application in production of conjugated linoleic acid, which belongs to the technical fields of protein engineering and microbial engineering. The linoleic acid isomerase derived from Bifidobacterium is used to produce the conjugated linoleic acid. The recombinant E. coli containing the linoleic acid isomerase of the invention is added into a reaction system containing linoleic acid and react for 3 h to produce conjugated linoleic acids. The conversion rate of the conjugated linoleic acid of the invented method ranges from 12.1% to 42.1%, and the percentage of cis9, trans11-CLA in the conjugated linoleic acid can reach 84.3% to 89.1%. The invention provides a method for using microorganisms to produce conjugated linoleic acids with high safety and yield where cis9, trans11-CLA isomer is the major form in the conjugated linoleic acid products.
    Type: Application
    Filed: October 10, 2021
    Publication date: January 20, 2022
    Applicant: Jiangnan University
    Inventors: Haiqin Chen, Bo Yang, He Gao, Jianxin Zhao, Yongquan Chen, Hao Zhang, Wei Chen
  • Patent number: 11224333
    Abstract: A stereo endoscope including: a shaft; and an objective lens including: a distal objective lens portion, where beam paths of right and left partial images extend through common optical components; a proximal objective lens portion, where the beam paths of the right and left partial images extend through separate optical components; and a transition portion, where the beam paths of the right and left partial images, which emerge from the distal objective lens portion at an angle to one another, are aligned parallel to one another; the transition portion comprises a lateral spreading arrangement including optical components for increasing a distance between the beam paths of the right and left partial images; and the lateral spreading arrangement is configured to laterally spread the beam paths of the right and left partial images asymmetrically in relation to an optical axis of the distal objective lens portion.
    Type: Grant
    Filed: October 1, 2018
    Date of Patent: January 18, 2022
    Assignee: OLYMPUS WINTER & IBE GMBH
    Inventor: Jianxin Zhao